rs137852603

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP5BP4

The NM_130439.3(MXI1):​c.656A>C​(p.Glu219Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,457,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

MXI1
NM_130439.3 missense

Scores

5
13

Clinical Significance

Pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 3.58

Publications

4 publications found
Variant links:
Genes affected
MXI1 (HGNC:7534): (MAX interactor 1, dimerization protein) Expression of the c-myc gene, which produces an oncogenic transcription factor, is tightly regulated in normal cells but is frequently deregulated in human cancers. The protein encoded by this gene is a transcriptional repressor thought to negatively regulate MYC function, and is therefore a potential tumor suppressor. This protein inhibits the transcriptional activity of MYC by competing for MAX, another basic helix-loop-helix protein that binds to MYC and is required for its function. Defects in this gene are frequently found in patients with prostate tumors. Three alternatively spliced transcripts encoding different isoforms have been described. Additional alternatively spliced transcripts may exist but the products of these transcripts have not been verified experimentally. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-110280017-A-C is Pathogenic according to our data. Variant chr10-110280017-A-C is described in ClinVar as Pathogenic. ClinVar VariationId is 9536.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.17194998). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_130439.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MXI1
NM_130439.3
MANE Select
c.656A>Cp.Glu219Ala
missense
Exon 5 of 6NP_569157.2P50539-3
MXI1
NM_005962.5
c.455A>Cp.Glu152Ala
missense
Exon 5 of 6NP_005953.4
MXI1
NM_001008541.1
c.317A>Cp.Glu106Ala
missense
Exon 4 of 5NP_001008541.1P50539-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MXI1
ENST00000332674.9
TSL:1 MANE Select
c.656A>Cp.Glu219Ala
missense
Exon 5 of 6ENSP00000331152.5P50539-3
MXI1
ENST00000239007.11
TSL:1
c.455A>Cp.Glu152Ala
missense
Exon 5 of 6ENSP00000239007.7P50539-1
MXI1
ENST00000361248.8
TSL:1
c.317A>Cp.Glu106Ala
missense
Exon 4 of 5ENSP00000354606.4P50539-4

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.86e-7
AC:
1
AN:
1457990
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
725540
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33414
American (AMR)
AF:
0.00
AC:
0
AN:
44436
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26032
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39610
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
85856
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53240
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5740
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1109544
Other (OTH)
AF:
0.00
AC:
0
AN:
60118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Prostate cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.099
T
BayesDel_noAF
Benign
-0.38
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T
Eigen
Uncertain
0.19
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.17
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.9
M
PhyloP100
3.6
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.073
Sift
Benign
0.073
T
Sift4G
Benign
0.35
T
Polyphen
0.93
P
Vest4
0.34
MutPred
0.20
Gain of MoRF binding (P = 0.0248)
MVP
0.20
MPC
1.4
ClinPred
0.72
D
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.24
gMVP
0.25
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137852603; hg19: chr10-112039775; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.